Stryker Co. (NYSE:SYK) Stock Position Decreased by Illinois Municipal Retirement Fund


Share on StockTwits

Illinois Municipal Retirement Fund trimmed its stake in Stryker Co. (NYSE:SYK) by 38.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,010 shares of the medical technology company’s stock after selling 7,974 shares during the period. Illinois Municipal Retirement Fund’s holdings in Stryker were worth $3,169,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Clarius Group LLC grew its holdings in shares of Stryker by 1.3% during the 1st quarter. Clarius Group LLC now owns 3,001 shares of the medical technology company’s stock worth $731,000 after purchasing an additional 38 shares in the last quarter. Stratos Wealth Partners LTD. raised its position in Stryker by 3.9% in the 1st quarter. Stratos Wealth Partners LTD. now owns 12,039 shares of the medical technology company’s stock valued at $2,932,000 after purchasing an additional 449 shares during the last quarter. Fisher Asset Management LLC raised its position in Stryker by 5.1% in the 1st quarter. Fisher Asset Management LLC now owns 2,706,178 shares of the medical technology company’s stock valued at $659,171,000 after purchasing an additional 132,119 shares during the last quarter. PFG Advisors raised its position in Stryker by 4.4% in the 1st quarter. PFG Advisors now owns 12,622 shares of the medical technology company’s stock valued at $3,074,000 after purchasing an additional 532 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its position in Stryker by 6.9% in the 1st quarter. Pinnacle Bancorp Inc. now owns 1,702 shares of the medical technology company’s stock valued at $415,000 after purchasing an additional 110 shares during the last quarter. 71.46% of the stock is currently owned by hedge funds and other institutional investors.

In other news, VP M Kathryn Fink sold 4,000 shares of the stock in a transaction on Thursday, April 8th. The stock was sold at an average price of $250.00, for a total value of $1,000,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Glenn S. Boehnlein sold 2,000 shares of the stock in a transaction on Monday, March 1st. The shares were sold at an average price of $246.01, for a total value of $492,020.00. Following the completion of the transaction, the chief financial officer now owns 12,321 shares of the company’s stock, valued at $3,031,089.21. The disclosure for this sale can be found here. Company insiders own 6.80% of the company’s stock.

Several brokerages have issued reports on SYK. Robert W. Baird lifted their price objective on Stryker from $265.00 to $292.00 and gave the company an “outperform” rating in a research report on Wednesday, April 28th. JPMorgan Chase & Co. boosted their target price on Stryker from $245.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 2nd. Oppenheimer boosted their target price on Stryker from $240.00 to $273.00 in a research report on Wednesday, April 28th. Truist Securities boosted their target price on Stryker from $245.00 to $255.00 in a research report on Wednesday, April 28th. Finally, Raymond James lifted their price objective on Stryker from $255.00 to $290.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 28th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Stryker has a consensus rating of “Buy” and an average target price of $261.59.

Shares of NYSE:SYK opened at $263.10 on Tuesday. The company has a market capitalization of $99.12 billion, a P/E ratio of 57.07, a P/E/G ratio of 2.79 and a beta of 0.87. Stryker Co. has a 1 year low of $171.75 and a 1 year high of $268.04. The company has a debt-to-equity ratio of 0.92, a current ratio of 2.89 and a quick ratio of 2.15. The business’s 50 day simple moving average is $249.13 and its 200 day simple moving average is $238.13.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Monday, April 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.99 by ($0.06). The company had revenue of $3.95 billion for the quarter, compared to analyst estimates of $3.94 billion. Stryker had a return on equity of 20.94% and a net margin of 12.35%. The company’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 EPS. On average, sell-side analysts anticipate that Stryker Co. will post 7.18 EPS for the current fiscal year.

Stryker Company Profile

Stryker Corp. engages in the provision of medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The MedSurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling and reprocessed medical devices.

Featured Article: Certificate of Deposit (CD) For Risk Adverse Investors?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.